Understanding of Participation Trends Within Generalized Anxiety Disorder Patients Involved in Clinical Trials

N/ANot Yet RecruitingNCT06254157

Power Life Sciences Inc.500 enrolled

Overview

Typically, certain demographic groups tend to participate more in medical research. However, there is insufficient research explaining the trial characteristics that influence the involvement of these specific demographics. This study aims to collect extensive data on the clinical trial experiences of individuals with generalized anxiety disorder. The goal is to identify the factors that hinder a patient's enrollment or completion of a trial. Additionally, the research will examine the data from various demographic perspectives to identify recurring patterns that could offer valuable insights for future generalized anxiety disorder patients.

Study Type

OBSERVATIONAL

Enrollment

500

Conditions

Generalized Anxiety Disorder

Eligibility

Sex: ALLMin age: 18 Years

Medical Language ↔ Plain English

Inclusion Criteria: * Confirmed diagnosis of generalized anxiety disorder * Participant must be 18 years of age or older * Participant must be willing and able to comply with scheduled visits, treatment schedule, laboratory tests, and other requirements of the study. Exclusion Criteria: * Pregnant or lactating woman * Participant is actively receiving study therapy in another * Inability to provide written informed consent

Locations (1)

Power Life Sciences

San Francisco, California, United States

Outcomes

Primary Outcomes

Rate of patients who decide to enroll in a generalized anxiety disorder clinical research.

Time frame: 3 months

Number of generalized anxiety disorder study participants who remain in clinical study until completion.

Time frame: 12 months